Clinicopathological and prognostic significance of cancer stem cell markers CD44 and CD133 in patients with gastric cancer: A comprehensive meta-analysis with 4729 patients involved

BACKGROUND: In recent years, CD44 and CD133 have been identified as 2 common used cancer stem cell (CSC) markers in gastric cancer. However, the clinicopathological and prognostic value of these markers in gastric cancer remains controversial; moreover, there is lack of comparison of these 2 markers...

Descripción completa

Detalles Bibliográficos
Autores principales: Lu, Li, Wu, Menglin, Sun, Longhao, Li, Weidong, Fu, Weihua, Zhang, Xuening, Liu, Tong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2016
Materias:
4500
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5079331/
https://www.ncbi.nlm.nih.gov/pubmed/27759647
http://dx.doi.org/10.1097/MD.0000000000005163

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5079331/
https://www.ncbi.nlm.nih.gov/pubmed/27759647
http://dx.doi.org/10.1097/MD.0000000000005163

Ejemplares similares